baber/WOPTO huggingface dataset:
Patent DK-409087-D0 (DK)
Inventor: WELTER ANDRE
IPC: C07D333/36
Filed: 1987-08-05
Abstract: The present invention is related to new diselenobis benzoic acid amides of primary heterocyclic amines of the general formula I <CHEM>  wherein R<1> and R<2>, which are equal or different from another, represent hydrogen, halogen, C1-4-alkyl, C1-4-alkoxy, trifluoromethyl, nitro or, both together, methylenedioxy,  n is zero or a numeral from 1 to 4 and R<3> is a saturated or unsaturated heterocyclic residue with one or two heteroatoms in the cyclic nucleus selected from the group of nitrogen, sulphur and oxygen, said residues being unsubstituted or substituted onces or twice, equally or in different manner, by halogen, C1-2-alkyl, C1-2-alkoxy, nitro or hydroxy. processes for producing the same and pharmaceutical compositions comprising the same. The compounds of formula I are useful in the treatment of diseases which are caused by cell damage due to the increased formation of active oxygen metabolites such as liver damages, heart infarctions, infections, psoriasis or damages by radiation.
Patent DK-415789-D0 (DK)
Inventor: WIERINGA JOHANNES HUBERTUS
IPC: C07D495/04
Filed: 1989-08-23
Abstract: The invention relates to novel tetracyclic compounds with an anti-depressant action, without neuroleptic or sedative side effects, of the general formula I <CHEM>  and also functional derivatives hereof, wherein: R<1> represents one or two identical or different substituents denoting H, OH, halogen C1-C4 alkyl or C1-C4 alkoxy; R<2> represents one or two identical or different substituents having the same meaning as R<1>; R<3> and R<4> are two substituents which are in the cis configuration and of which one is H and the other is OH;  R<5> is H or C1-C4 alkyl;  X denotes O or S; n is O or 1. h
Patent DK-417983-D0 (DK)
Inventor: DENEKE ULFERT
IPC: C12Q1/48
Filed: 1983-09-14
Abstract: The present invention provides a process for the kinetic determination of  gamma -glutamyl transferase activity by the reaction of a  gamma -glutamylarylamide with the formation of an arylamine at a pH value of from 6 to 10, wherein the arylamine is simultaneously reacted with an aromatic amine or phenol appropriate as a coupling component and an appropriate oxidation agent to give a colored compound with an absorption maximum above 565 nm, the rate of formation of which is monitored photometrically and is used as a measure for the  gamma -glutamyl transferase activity. The present invention also provides a reagent for the kinetic determination of gamma -GT activity, wherein it contains the following reagents: gamma -GT-arylamide:1-100 mmol/l.  gamma -glutamyl acceptor (glycylglycine):10-500 mmol/l. coupling component:1-500 mmol/l. oxidation agent:0.1-500 mmol/l. buffer:10-1000 mmol/l.
Patent DK-591089-D0 (DK)
Inventor: VAUGHAN RODNEY GEORGE
IPC: B62D63/08
Filed: 1989-11-24
Abstract: A mobile vehicle inspection facility (10) which is provided with a towing hitch (12) to enable the facility (10) to be towed by a prime mover. The facility (10) includes a brake testing assembly (27) which provides an indication of the condition of the brakes of a vehicle being tested. The brake testing assembly (27) also incorporates load cells (60) which provide a signal indicative of the weight carried by the wheels being tested. The facility (10) further includes a steering and suspension play detection assembly (36) which is used to determine the play in the steering and suspension of the vehicle. The brake testing assembly (27) and the steering and suspension play detection assembly (36) are aligned transversely of the facility (10) so that a vehicle being tested may move transversely of the facility (10) between the brake testing assembly (27) and the steering suspension play detection assembly (36). The facility (10) has wheel assemblies (13) which are movable from a transport position supporting the facility (10), to an inoperative position allowing the test vehicle to move transversely of the facility (10).
Patent HU-9202051-D0 (HU)
Title: A stimulator of vascularis endothelialis cells and its application
Inventor: XIU RUI-JUAN
IPC: A61K36/07
Filed: 1990-12-21
Abstract: The use of extracts of Tremella fuciformis (Berk) in maintaining the permeability of microvascular walls and its effect on the microcirculatory system, especially with regard to treatment of thromboplebitis, atherosclerosis and senile degradation of microvessels, is described.
Patent HU-905471-D0 (HU)
Title: Process for producing penem derivatives
Inventor: PERRONE ETTORE
IPC: C07D499/06
Filed: 1990-07-03
Abstract: There is provided a process for the preparation of compounds of formula (I) useful as antibacterials: <CHEM> wherein R represents hydrogen atom or a hydroxy protecting group, which process comprises reacting a compound of formula (II) <CHEM> wherein R is as defined above, with an oxalyl halide in an inert solvent; optionally converting the resultant compound of the formula III <CHEM> wherein R is as defined above and X is a halogen atom into a compound of the formula III in which X represents a hydroxy group by hydrolysis; either (i) treating the compound of formula III in which X is a halogen atom with a compound of the formula IV <CHEM> wherein Y is a hydroxy group in the presence of an acid scavenger or an organic or inorganic base or (ii) treating the compound of the formula III in which X is a hydroxy group, with a compound of the formula IV in which Y is a leaving group in the presence of a base; cyclizing the resultant compound of the formula V <CHEM> wherein R is as defined above and optionally deprotecting the resultant compound of the formula I wherein R is a hydroxy protecting group to obtain a compound of the formula I wherein R is a hydrogen atom.
Patent NO-881351-D0 (NO)
Inventor: BENGTSSON ERIK ALVAR
IPC: C01B15/023
Filed: 1988-03-25
Abstract: A process for the production of hydrogen peroxide according to the anthraquinone process. According to the process certain alkyl substituted caprolactames are used as solvents, and particularly as solvents for anthrahydroquinones. The substituted caprolactames, which for example can be hexyl caprolactam and octyl caprolactam, give a very good solubility for anthrahydroquinones and also for anthraquinones. The compounds can be used as the sole solvent at the production of hydrogen peroxide or in combination with conventionally used solvents such as hydrocarbons.
Patent NO-890996-D0 (NO)
Inventor: SAKANE KAZUO
IPC: A61K31/545
Filed: 1989-03-08
Abstract: A compound of the formula : <CHEM>  wherein R<1> is amino or a protected amino group,  R<2> is an organic group, R<3> is hydrogen, lower alkyl, hydroxy(lower)alkyl, protected hydroxy(lower)alkyl, amino(lower)alkyl, protected amino(lower)alkyl or an imino protective group,  R<4> is hydrogen, lower alkyl or lower alkylthio, A is lower alkylene which may be substituted with suitable substituent(s) and  Z is N or CH, and a pharmaceutically acceptable salt thereof, processes for its preparation and pharmaceutical compositions comprising them or a pharmaceutically acceptable salt thereof in admixture with pharmaceutically acceptable carriers.
Patent NO-892993-D0 (NO)
Inventor: LANGER RUTH
IPC: E04H3/28
Filed: 1989-07-21
Abstract: The podium (20) has a support construction (23) on which the floor elements (22) are laid. The latter have panels (35) on which people can walk and which lie on a frame. The frame is formed with rectangular tubes (36.1, 36.2), standing on edge, for each floor element. These rectangular tubes are connected by square tubes (37) running transversely. Pivotable eye bolts (48) are fastened to these square tubes (37) as clamping elements and are clamped securely by nuts under cover plates (30) - pivoted in slots on the end side of the latter. Erection and disassembly are simple. The mounting is stable and reliable. <IMAGE>
Patent NO-905103-D0 (NO)
Inventor: HILLE THOMAS
IPC: A61P17/00
Filed: 1990-11-26
Abstract: The controlled delivery of buprenorphine or its pharmaceutically compatible salts over at least 24 hours onto the skin is ensured by a transdermal therapeutic system composed of a backing layer which is impermeable to active substance, of an adhesive reservoir layer and, where appropriate, of a protective layer which can be detached again, which system is characterised in that the reservoir layer contains 20-90% by weight of polymeric material, 0.1-30% by weight of plasticiser, 0.1-20% of buprenorphine base or of one of its pharmaceutically acceptable salts and 0.1-30% by weight of solvent for the active substance base.
Patent NO-920576-D0 (NO)
Inventor: URIBE JUAN ANGELES
IPC: A61K9/52
Filed: 1992-02-13
Abstract: Non-porous solid microspheres have a dia. of 5-300 microns and consist of a mixt. of at least one injectable drug and a carrier. Provided the carrier is a substance naturally present in the recipient organism, it is stable in the solid state at temps. up to at least 60 deg. C and in the recipient physiological medium, and has dissolution kinetics in the recipient organism that are slower than the release kinetics of the drug in the same organism. Carrier is pref. coprosterol, glycocholic acid, cholesterol or a cholesterol este. Drug is pref. e.g, lorazepam, haloperidol, diazepam, biperiden, trihexyphenidyl.HCl, clonazepam, morphine, metoclopramide, acepromazine maleate, domperidone, vincamine etc. Microspheres are produced by dispersing the drug in the carrier, melting the mixt. in an inert gas atmos., spraying the melt under inert gas pressure, cooling the spray to solidify the droplets, and screening the resulting microspheres.
Patent NO-924170-D0 (NO)
Inventor: ARBOGAST FRANZ
IPC: F04C2/10
Filed: 1992-10-29
Abstract: The invention relates to an internal-gear pump having at least two essentially identical internally geared ring gears (6', 6'') and a pinion (5) jointly meshing with the ring gears, all of which are rotatably supported in a jointly supported casing section (1) whose axial extent corresponds to the width (B) of the gearing (12) of the ring gears (6', 6'') and the pinion (5) and which has a suction connection (7) and a discharge connection (10), the ring gears (6', 6'') having radial openings (17) for the medium to be pumped. The invention is characterised in that in the area of the contact faces of the ring gears there is provided, as seen from the discharge connection side, an abutment (25). 
<IMAGE>
Patent NO-941899-D0 (NO)
Inventor: ROLIN INGMAR ERIK
IPC: F24F3/044
Filed: 1994-05-20
Abstract: PCT No. PCT/FI92/00306 Sec. 371 Date May 20, 1994 Sec. 102(e) Date May 20, 1994 PCT Filed Nov. 11, 1992 PCT Pub. No. WO93/10403 PCT Pub. Date May 27, 1993Air-conditioning installation for room spaces (1), comprising a heat transfer device (4) for preheating supply air (A) by transferring heat from exhaust air (B) into the supply air; heating means including a heating source (11) for further heating the supply air; cooling means including a cooling source (14) for cooling the supply air; and adjusting means (16, 17, 18, 21, 32, 33, 34) for sensing the temperature of the supply air and for controlling the heat transfer device and the heating and cooling means on the basis of the sensed temperature. To simplify the structure of the installation, the heating and cooling sources (11, 14) are connected to the heat transfer device (4) so that the preheating, further heating and cooling of the supply air take place through the common heat transfer device.
Patent NO-943845-D0 (NO)
Inventor: PIZZI ANTONIO
IPC: C08G83/00
Filed: 1994-10-12
Abstract: The invention relates to novel binders which can be cured at elevated temperatures and are compatible with cellulose-containing materials, for example wood, and are suitable for the production of wood materials, such as chipboard. They comprise tannins and weakly acidic compounds.
Patent NO-964939-D0 (NO)
Inventor: ROSENBERG JOERG
IPC: A61K9/20
Filed: 1996-11-20
Abstract: PCT No. PCT/EP96/01047 Sec. 371 Date Nov. 21, 1996 Sec. 102(e) Date Nov. 21, 1996 PCT Filed Mar. 12, 1996 PCT Pub. No. WO96/29061 PCT Pub. Date Sep. 26, 1996A process for producing active substance compositions in the form of a solid solution of the active substance in a polymer matrix, which comprises melt extrusion of the active substance in nonionic form together with a polymer and a salt.
Patent NO-974044-D0 (NO)
Inventor: MERKLE HANS RUPERT
IPC: C07D231/12
Filed: 1997-09-03
Abstract: PCT No. PCT/EP96/00790 Sec. 371 Date Aug. 20, 1997 Sec. 102(e) Date Aug. 20, 1997 PCT Filed Feb. 27, 1996 PCT Pub. No. WO96/27589 PCT Pub. Date Sep. 12, 1996A process for the preparation of an N-alkyl- or N-phenylalkyl-substituted pyrazole I by reacting the corresponding N-unsubstituted pyrazole II with an alcohol III of the formula R1-OH where R1 is the same alkyl or phenylalkyl group to be added to the unsubstituted nitrogen group -NH- of the pyrazole reactant. Both of the reactants, i.e. the pyrazole II and alcohol III compounds, are catalytically reacted in the liquid phase in a molar ratio of from 0.001:1 to 1:1, at temperatures of 50 DEG -400 DEG  C. and under a subatmosheric pressure of from 0.8 bar up to a superatmospheric pressure of 250 bar. The catalyst required for this liquid phase reaction is selected as being at least one or more non-heterogeneous acid catalysts, their alkyl esters or their acid anhydrides.
Patent GB-0007419-D0 (GB)
Title: Composition
IPC: A23L33/155
Filed: 2000-03-27
Abstract: A therapeutic formulation in the form of a beadlet, suitable for oral administration and adapted to provide immediate and sustained release of therapeutic material. Each beadlet comprises an extruded-spheronized inner core containing at least one medicament e.g. a slow release vitamin, an outer layer containing at least one medicament e.g. a fast release vitamin and a controlled release coating between the inner core and the outer layer which coating controls the release of the inner core medicament.
Patent GB-0100397-D0 (GB)
Title: Medical respiratory apparatus
IPC: A61M11/00
Filed: 2001-01-06
Abstract: A medical respiratory apparatus includes a chamber (10) which is at least in part at least translucent. The chamber (10) includes a float member (12) formed of an inert material and contains, in use, a fluid intended for inhalation. The float member (12) is adapted to float upon the fluid intended to be contained within the chamber (10) and has a peripheral dimension adjacent, but less than, the internal peripheral dimension of the chamber (10). At least the outer peripheral surface of the float member (12) has a coloration distinct from that of the fluid to be contained within the chamber such that the level of the fluid within the chamber (10) can be readily observed.
Patent GB-0416315-D0 (GB)
Title: Herbo-mineral formulation for refractory leukemias and lymphomas
IPC: A61K36/74
Filed: 2004-07-21
Abstract: A pharmaceutical or medicinal preparation comprising a mixture of arsenic trioxide (As2O3) and the herbs Aloe Vera (Aloe Barbedensis), Withania Somnifera, Glycine Max, Rubia Cordifolia and Acacia Catechu, or a mixture of the active ingredients that have been extracted from those herbs. The herbomineral formulation of the invention is effective for the treatment of cancer, in particular refractory leukemias, lymphomas, myelodysplastic syndrome and aplastic anemias.
Patent GB-0604434-D0 (GB)
Title: 2 hour fire rated with upto 64 decible rating electrical dry lining socket back box
Filed: 2006-03-04
Abstract: An electrical socket back box 1 comprises an inner casing 2, an outer casing 4 and an integral layer of insulating material 6, which may be acoustic mastic. The inner casing 2 and outer casing 4 are composed of a hard plastic material. The insulating material 6 provides insulation of up to 64 dB acoustic rating and 2 hours fire rating. The layer of insulating material 6 is press moulded onto the rear surface of the inner casing 2 and the outer casing 4 is press moulded onto the layer of insulating material 6.
Patent GB-0623761-D0 (GB)
Title: Interface between network data bus application and avionics data bus
Filed: 2006-11-28
Abstract: A method for transmitting data between a first device and second device is disclosed. The method includes receiving a block of data; dividing the block of data into at least a first packet having a first size and a second packet having a second packet size; transmitting the first packet to a converter, the converter being configured to convert a packet from a first communication protocol to a second communication protocol; and transmitting the second packet to the converter after waiting a predetermined time. The first packet size, the second packet size, and the predetermined time are selected to prevent overflow of a memory of the converter. The second packet size, and the predetermined time are selected to prevent expiration of a timer at the second data bus. The time is associated with data transferred in the first and second packets.
Patent GB-0900652-D0 (GB)
Title: Drive mechanism for selectively switching a drive between propulsion and torque vectoring mode
IPC: F16H48/30
Filed: 2009-01-16
Abstract: A hybrid vehicle is provided with a drive mechanism for transmitting torque to at least a first and a second output member as well as to such a drive mechanism. The drive mechanism includes, but is not limited to a torque generating drive member operably coupled to the first and second output members, a switching element operably coupled to the drive member for selectively coupling the drive member with the first and second output members either in a propulsion mode or in a vector mode. In the propulsion mode, the drive member's torque is inducted to first and second output members uni-directionally and in the vector mode, the drive member's torque is inducted to first and second output members in opposite directions.
Patent GB-0907704-D0 (GB)
Title: Methods and systems for monitoring position and movement of human beings
Filed: 2007-10-11
Abstract: Methods and systems for detecting a predetermined position of a user wearing a disposable absorbent article are given. The methods and systems may include detecting that the user of the disposable absorbent article is in the predetermined position, wherein the predetermined position is determined to be a potentially life-threatening position. In response to determining that the user is in the predetermined position, an operation of a transmitter located on the disposable absorbent article is controlled. Movement, location and/or various biometrics of the user may also be monitored.
Patent GB-0911493-D0 (GB)
Title: Catalysed dye systems
Filed: 2009-07-02
Abstract: The present invention is concerned with a dye system for application to a substrate, the dye system comprising: (a) at least one dye precursor; (b) an oxidizing agent; and (c) a catalyst, wherein the catalyst is a homogeneous catalyst or a heterogeneous catalyst. Preferably, the catalyst comprises at least one metal-containing compound. The invention also envisages a method for the coloration of a substrate, the method comprising treating the substrate with the dye system of the invention. In preferred embodiments of the invention, the substrate comprises human hair, natural or synthetic polymers, or textile fibers. In further preferred embodiments, the at least one dye precursor is an organic precursor, the at least one metal derivative for use as a catalyst comprises at least one inorganic metal compound or at least one metal complex comprising at least one organic ligand, and the oxidizing agent is hydrogen peroxide.
Patent GB-8408849-D0 (GB)
Title: Polymers containing anhydride groups
IPC: C08F8/48
Filed: 1984-04-05
Abstract: A polymer containing cyclic carboxylic acid anhydride groups is prepared by copolymerising an olefinically unsaturated polycarboxylic acid with at least one olefinically unsaturated comonomer, which is in solution in an organic solvent, at elevated temperature to form a copolymer solution. The solution is heated during and/or after polymerisation under conditions such that water is removed from the reaction medium. The polycarboxylic acid contains two carboxylic acid groups which are in such a configuration that the acid is capable of forming a cyclic anhydride and is preferably a dicarboxylic acid, for example itaconic acid.
Patent GB-8432073-D0 (GB)
Title: Chemical compounds
IPC: C07D487/04
Filed: 1984-12-19
Abstract: Novel compounds selected from the group consisting of the formula <IMAGE>  I  wherein R1 is selected from the group consisting of 1,2,4-oxadiazol-5-yl and 1,3,4-thiadiazol-2-yl, both optionally substituted with alkyl of 1 to 3 carbon atoms or alkenyl of 2 to 5 carbon atoms and 1,2,4-oxadiazol-3-yl and 1,3,4-oxadiazol-2-yl, both optionally substituted with alkenyl of 2 to 5 carbon atoms, alkyl of 1 to 3 carbon atoms or alkyl of 1 to 3 carbon atoms substituted with at least one fluorine, R2 and R3 are individually selected from the group consisting of hydrogen, alkyl of 1 to 3 carbon atoms and alkenyl of 2 to 5 carbon atoms or together form alkylene of 3 to 5 carbon atoms, X is selected from the group consisting of -O- and -S-, R4 is alkyl of 1 to 3 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having anxiolytic sedative and hypnotic activity and a novel process and novel intermediates therefor.
Patent GB-8519557-D0 (GB)
Title: Tag assemblies
IPC: F23M9/06
Filed: 1985-08-03
Abstract: Male and female tag members 2' and 3' have respectively a projecting portion 5' for extending through the part to be tagged and a receiving portion 10' for accommodating an end part of the projecting portion 5' after it has passed through the part to be tagged. The receiving portion 10' is in the form of a closed container defining a cylindrical chamber 11' containing sterilising substance. The action of fitting the tag assembly to the part to be tagged causes the projecting portion 5' to pierce a weakened portion 14' of a wall of the chamber 11' resulting in release of sterilising substance from the chamber 11', for example for sterilising the wound formed when the assembly is fitted to an animal's ear. In a variant the sterilising substance is replaced by a substance having active pharmaceutical properties.
Patent GB-8609697-D0 (GB)
Title: Drive unit for motor vehicles
IPC: F16H3/66
Filed: 1983-12-22
Abstract: In a drive unit for motor vehicles, the axes of rotation of the main shaft of an engine and an input wheel of an intermediate transmission are arranged in line with one another in relation to one of two parallel geometrical main axes, and the axes of rotation of an output shaft, couplable to a differential, of a gear-change transmission of epicyclic design, of a transmission member connected fixedly in terms of rotation to the output shaft and belonging to an epicyclic transmission and of the output wheel of the intermediate transmission are arranged in line with one another in relation to the other main axis. The input shaft of the gear-change transmission can be driven from the main shaft. The output wheel can be brought into drive-connection with another transmission member of the epicyclic transmission which has the transmission member connected fixedly in terms of rotation to the output shaft. To allow a gear-change transmission with more than four forward gears to be accomodated, the axes of rotation of the input shaft of a drive clutch and of a transmission member, couplable to the input shaft by means of the drive clutch and belonging to an epicyclic transmission, which has a transmission member which can be brought into drive-connection with the input wheel, are arranged in line with one another relative to the main axis of the main shaft.